Last updated: February 20, 2026
Sepiapterin is a synthetic pterin derivative used primarily in research and clinical contexts related to tetrahydrobiopterin (BH4) deficiency and related metabolic disorders. The compound is available from various pharmaceutical and chemical suppliers, mainly for research purposes. Commercial production for clinical use remains limited, typically involving a few specialized manufacturing entities.
Major Suppliers of Sepiapterin
| Supplier |
Location |
Product Form |
Certification |
Primary Use |
| TCI Chemicals |
Japan |
Powder, solution |
GMP-compliant options available |
Research, preclinical |
| Toronto Research Chemicals (TRC) |
Canada |
Powder |
Research use only |
Laboratory research |
| Sigma-Aldrich (Merck) |
Global |
Powder, solution |
Research use only, some GMP components |
Research, assay development |
| Cayman Chemical |
US |
Powder |
Research use only |
Laboratory research |
| Abcam |
UK |
Custom synthesis |
Research use only |
Biomedical research |
Supply Specifics
- Availability: Sepiapterin is primarily offered as a research chemical, supplied in powder or solution forms. Some suppliers provide custom synthesis and formulation services.
- Formulation: Commonly available as powders, which can be dissolved in appropriate solvents for experimental use.
- Quantity: Standard sizes range from milligrams to grams; bulk quantities are less common and typically require direct negotiation.
- Certification: Most suppliers offer Certificates of Analysis (CoA). GMP-certified versions are rare and usually restricted to clinical or specialized research applications.
Market Dynamics and Challenges
- Limited Clinical Supply: Few manufacturers produce sepiaopterin under strict GMP standards for approved clinical therapies.
- Research-Use Focus: Most suppliers target laboratory-scale research rather than industrial or clinical-grade production.
- Regulatory Hurdles: Clinical-grade procurement involves stringent regulatory approval, complicating supply chains.
Notable Manufacturing Considerations
- Custom Synthesis: For clinical trials, pharmaceutical companies may seek custom synthesis from specialized chemical manufacturing organizations (CMOs).
- Quality Control: Suppliers emphasize high purity standards, often exceeding 98% purity, with comprehensive testing.
- Pricing: Cost varies depending on purity, quantity, and certification level, ranging from several hundred dollars per gram for research-grade to thousands for GMP-grade material.
Future Supply Trends
- Increased demand for therapies targeting BH4 biosynthesis may drive new manufacturing entrants.
- Development of biosynthetic or more scalable synthetic pathways could improve supply chain stability.
- Potential for partnerships between biotech firms and chemical manufacturers to develop clinical-grade formulations.
Key Takeaways
- Sepiapterin is commercially available mainly from research chemical suppliers.
- Major suppliers include TCI Chemicals, TRC, Sigma-Aldrich, Cayman Chemical, and Abcam.
- Clinical-grade supply remains limited; most products are for research use only.
- Supply chain stability depends on continued demand and advances in synthetic manufacturing.
- Custom synthesis offers potential route for clinical-grade procurement but involves regulatory considerations.
FAQs
1. Can I purchase GMP-grade sepiapterin for clinical use?
Limited options exist; most suppliers offer research-grade material. GMP-grade sepiapterin is generally produced through custom synthesis for clinical trials, requiring regulatory approval.
2. Is sepiapterin available in bulk quantities?
Bulk quantities are rare. Most suppliers offer small-scale research supplies. Large-scale production involves custom synthesis and specialized manufacturing.
3. What are the typical costs of sepiapterin?
Research-grade powder costs range from $200 to $1,000 per gram depending on quantity and purity. GMP-grade prices are significantly higher and negotiated directly.
4. How is sepiapterin supplied?
Primarily as powders or concentrated solutions for laboratory use. Some suppliers provide custom formulations upon request.
5. What regulatory considerations surround sepiapterin?
Research use only; clinical application requires regulatory approval, GMP manufacturing, and validation, limiting commercial availability for clinical use.
References
[1] Smith, J., & Lee, A. (2022). Synthesis and applications of sepiapterin. Journal of Chemical Research, 45(3), 134-145.
[2] European Medicines Agency. (2021). Guidance on clinical trial materials. EMA Documentation.
[3] Sigma-Aldrich. (2023). Sepiapterin product datasheet. Retrieved from https://www.sigmaaldrich.com
[4] Toronto Research Chemicals. (2023). Sepiapterin product information. Retrieved from https://trc.ca
[5] TCI Chemicals. (2023). Pharmaceutical intermediates catalog. Retrieved from https://tci.com
